Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Simon Kuster; Suzana Jordan; Muriel Elhai; Ulrike Held; Klaus Steigmiller; Cosimo Bruni; Fabio Cacciapaglia; Serena Vettori; Elise Siegert; Simona Rednic; Veronica Codullo; Paolo Airo; Yolanda Braun-Moscovici; Nicolas Hunzelmann; Maria Joao Salvador; Valeria Riccieri; Ana-Maria Gheorghiu; Juan José Alegre Sancho; Katarzyna Romanowska-Prochnicka; Ivan Castellví; Ina Kötter; Marie-Elise Truchetet; FJ López-Longo; Pavel I Novikov; Alessandro Giollo; Yuichiro Shirai; Laura Belloli; Elisabetta Zanatta; Eric Hachulla; Vanessa Smith; Chris Denton; Ruxandra M Ionescu; Tim Schmeiser; Joerg H W Distler; Armando Gabrielli; Anna-Maria Hoffmann-Vold; Masataka Kuwana; Yannick Allanore; Oliver Distler

doi:10.1136/rmdopen-2022-002477

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Systemic sclerosis

Original research

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Kuster S, Jordan S, Elhai M on behalf of the EUSTAR collaborators, et al

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

RMD Open 2022;8:e002477. doi: 10.1136/rmdopen-2022-002477

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password